The New Future of US Telehealth: Lasting Impacts of COVID-19

Ilya Trakhtenberg

future of US telehealth

COVID-19 expands use of telehealth

telehealth use cases

telehealth software ecosystem

eliminating telehealth barriers

COVID-19 and telehealth use cases

increased utilization of telehealth

hospital systems increase telehealth usage

virtual care and asynchronous visits biggest increases

structural and behavioral changes increase telehealth usage

patient and provider forced trial increase telehealth

waived regulatory and reimbursement restrictions with telehealth

forced trial to be lasting impact of COVID-19

telehealth expansion positive impacts and potential risks

telehealth evolution market

telehealth impact to payers and stakeholders

amazon and telehealth

For more information, please visit L.E.K.’s COVID-19 Insights Center or fill out this form to get in touch with us.

Related Insights

Life Sciences & Pharma

Executive Insights

AI in Biopharma: Realizing the Promise

October 31, 2019

Artificial intelligence (AI) should enable biopharma companies to tackle the entrenched inefficiencies of the costly and time-consuming drug development…

Paper & Packaging

Executive Insights

How Can Corporates and Private Equity Firms Win in Healthcare Packaging?

January 24, 2020

For both corporates and private investors looking to enter a lucrative market with long-term potential, healthcare packaging holds significant promise.

Life Sciences & Pharma

Executive Insights

Managing Non-Core Assets: Innovative Funding Models for Biopharma Companies

May 15, 2020

We discuss some of the innovative funding models available and identify the key strategies for optimizing these types of deals.

Life Sciences & Pharma

COVID-19

European Disease Progression Monitor: Edition 4

April 20, 2020

Italy, Spain and France are now several weeks past peak virus intensity, taking approximately two weeks to reach 50% of peak levels

Healthcare Services

Published Articles

The changing nature of healthcare investing in South East Asia and India

June 20, 2019

How will health investing in South East Asia (SEA) and India change, based on specific ‘weak signals’ for investment themes?

Life Sciences & Pharma

COVID-19

European Disease Progression Monitor: Edition 3

April 14, 2020

Weekly focus – A consistent pattern of lockdown exit strategies is emerging, with an initial focus on reopening childcare and small retail businesses.